The clinical promise of immunotherapy in triple-negative breast cancer

The clinical promise of immunotherapy in triple-negative breast cancer

Praveen Vikas,1,2 Nicholas Borcherding,2–5 Weizhou Zhang2–5 1Department of Internal Medicine, College of Medicine, University of Iowa, Iowa City, IA, USA; 2Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA; 3Department of Pathology, College of Medicine, U...

Full description

Bibliographic Details
Main Authors: Vikas P, Borcherding N, Zhang W
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Cancer Management and Research
Subjects:
Triple-negative breast cancer
immunotherapy
PD-1/PDL-1 antibody
CTLA-4 antibody
checkpoint inhibitors
cancer vaccines.
Online Access:https://www.dovepress.com/the-clinical-promise-of-immunotherapy-in-triple-negative-breast-cancer-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/the-clinical-promise-of-immunotherapy-in-triple-negative-breast-cancer-peer-reviewed-article-CMAR

Similar Items